News
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
FOX 32 Chicago on MSN6h
New weight-loss drug shows promiseWeight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
1h
Health and Me on MSNNovo Nordisk Launches Weight Loss Drug Wegovy In ThailandWegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...
Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like ...
Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
BORDERLINE alcoholic’ Shane Harding claims King Kong weight loss jab Mounjaro helped her shed six stone by curbing her ...
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results